Skip to main content

The Green Organic Dutchman Holdings Ltd (TGOD-T) Quote

Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Price Quote as of

Today's Trading

Day Low 0.77
Day High 0.84
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

The Green Organic Dutchman Holdings Ltd through its subsidiary operates as a cannabinoid-based research and development company in Canada. The company has two operating segments namely production and distribution of cannabis and related products and Hemp related products. It produces organic cannabis products, including organic dried cannabis, cannabis oils and edibles, fresh cannabis, and seeds for medical applications. Geographically, it generates maximum revenue from Europe.


Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Congress will Again Debate Federal Marijuana Legalization this Week
- PR Newswire - Tue Jan 14, 7:30AM CST
PR Newswire - CMTX
Tue Jan 14, 7:30AM CST
Cannabis is back in Congress. Just months after the House Judiciary Committee approved the Marijuana Opportunity Reinvestment and Expungement (MORE) Act, cannabis legalization will be the subject of another debate in and Commerce Subcommittee, reports Marijuana Moment. "As public opinion continues to evolve and cannabis policies change at all levels of government, it's important to bring federal agency officials together to discuss current and future federal cannabis policies," Energy and Commerce Chairman Frank Pallone (D-NJ) and Health Subcommittee Chairwoman Anna Eshoo said. "We're particularly interested in examining the implications of changing marijuana's schedule listing, the potential of cannabis research, and federal efforts to review and approve cannabidiol products." As excitement builds for potential rescheduling, it's creating sizable opportunity for companies including Terrace Global Inc. (TSX-V:TRCE), OrganiGram Holdings Inc. (NASDAQ:OGI)(TSX-V:OGI), The Green Organic Dutchman (TSX:TGOD)(OTCQX:TGODF), Canopy Growth Corporation (TSX:WEED)(NYSE:CGC), and Charlotte's Web Holdings Inc. (OTCQX:CWBHF) (CSE:CWEB).
Cannabis Infused Market Projected to Reach $17.27 Billion By 2022
- PR Newswire - Tue Dec 10, 7:55AM CST
PR Newswire - CMTX
Tue Dec 10, 7:55AM CST
It seems that every new report on projected revenues in the cannabis markets, global and U.S and North America, all seem to agree on one thing: The cannabidiol (CBD) revolution will continue to rise. An industry insider, Technavio, who has been monitoring the global cannabis-infused edible products market, recently projected that the market is poised to grow by USD $17.27 billion during 2018-2022 at a CAGR of over 25% during the forecast period. The market is driven by the growing social acceptance of cannabis. In addition, the increasing number of countries decriminalizing cannabis is anticipated to further boost the growth of the cannabis-infused edible products market. As consumers accept, and even demand more CBD products, the future is projected to continue to rise in years to come. The Technavio report said: "The cannabis industry has emerged as lucrative business segment with immense potential for market growth and is attracting many new vendors and large investors. This is due to the increasing social acceptance of recreational marijuana and cannabis-infused edible products across different regions. This has not only increased the sales and revenues of major corporations but has also significantly added to the income of several governments. Vendors are witnessing an increase in the growth opportunities in businesses involving cannabis-infused edible products such as brownies, ice creams, and chocolates. Thus, the growing social acceptance of cannabis is expected to drive market growth during the forecast period." Active Companies from around the market with current developments this week include: Singlepoint, Inc. (OTCQB: SING), Medical Marijuana, Inc. (OTCPK: MJNA), mCig, Inc. (OTCPK: MCIG), Canopy Growth Corporation (NYSE: CGC) (TSX: WEED), The Green Organic Dutchman Holdings Ltd. (OTCQX: TGODF) (TSX: TGOD).
US FDA Breakthrough Therapy Designation for Mushrooms Creating Big Opportunity
- PR Newswire - Thu Dec 5, 9:30AM CST
PR Newswire - CMTX
Thu Dec 5, 9:30AM CST
For the second year, the U.S. FDA designated psilocybin, a compound found in hallucinogenic mushrooms, as a "breakthrough therapy" for the treatment of major depressive disorder (MDD). "This designation, which is designed to expedite the development and review of drugs--given out only for therapies that have shown strong preliminary evidence in treating serious medical conditions--puts new pharmaceuticals on a fast track for approval and offers "intensive guidance" from the FDA," reports Popular Science. Even Researchers at New York University found psilocybin mushrooms caused a "rapid and sustained" reduction in anxiety and depression in patients with cancer, as reported by the Financial Post. That's all opening a range of opportunity for companies that have already established launching cannabis products including The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF), HEXO Corporation (NYSE:HEXO) (TSX:HEXO), Trulieve Cannabis Corp. (CSE:TRUL)(OTCQX:TCNNF), The Green Organic Dutchman (TSX:TGOD)(OTCQX:TGODF), and OrganiGram Holdings Inc. (NASDAQ:OGI) (TSX-V:OGI).
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 0.64 +20.31% increase
on 01/08/20
Period Open:0.79
Price movement based on the high, low and last over the given period.
0.84 -8.33% decrease
on 01/16/20
-0.02 (-2.53%) decrease
since 12/16/19
3-Month 0.62 +24.19% increase
on 11/18/19
Period Open:1.28
Price movement based on the high, low and last over the given period.
1.44 -46.53% decrease
on 10/17/19
-0.51 (-39.84%) decrease
since 10/16/19
52-Week 0.62 +24.19% increase
on 11/18/19
Period Open:2.98
Price movement based on the high, low and last over the given period.
5.81 -86.75% decrease
on 03/19/19
-2.21 (-74.16%) decrease
since 01/16/19

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies